Technical Assistance Webinars for RFA-NS-24-029 Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)"
Notice Number:
NOT-NS-24-036

Key Dates

Release Date:
November 27, 2023

Related Announcements

  • November 21, 2023 - Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required). See NOFO RFA-NS-24-029.

Issued by

National Institute of Neurological Disorders and Stroke (NINDS)

Purpose

The National Institute of Neurological Disorders and Stroke (NINDS) will be hosting pre-application, technical assistance webinars on?Tuesday, December 12,?2023 from?1PM 2PM (Eastern Time)?and on?Tuesday, January 9, 2024?from?1PM - 2PM (Eastern Time)?for all potential applicants interested in the following notice of funding opportunity (NOFO):

  • RFA-NS-24-029 Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)

This NOFO aims to encourage grant applications for the conduct of scientific research utilizing data from expanded access (EA) for investigational drugs or biological products. These applications will target?EA for intermediate size populations of patients?living with amyotrophic lateral sclerosis (ALS) who are not eligible for ongoing clinical trials for the prevention, diagnosis, mitigation, treatment, or cure of ALS.?

NIH program and review staff will provide an overview of the RFA, including objectives, application instructions and review criteria and will be available to answer questions. Potential applicants who wish to join in the webinar must pre-register for the webinar using the link(s) below.

We request that participants carefully review the funding opportunity for this initiative prior to joining the webinar. Participation in the webinar is optional and is not required for the submission of an application.

Webinar Information

Topic:?Technical Assistance Webinar: RFA-NS-24-029 - Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)

Dates:?Tuesday, Dec. 12, 2023 and Tuesday, Jan. 9, 2024

Time:?1PM - 2PM Eastern Time (ET)

To join the webinar, choose the date you would like to attend and pre-registration?through the following links:

Dec. 12: https://nih.zoomgov.com/webinar/register/WN_jrNS4LphTC66_d7g8j598g

Jan. 9: https://nih.zoomgov.com/webinar/register/WN_KFmFcfPQT8C0asR52JJe2w

Participants requiring sign language interpretation and/or other reasonable accommodations should contact elio.peraza@nih.gov at least 5 days prior to the event.

Participants can submit questions in advance to Elio Peraza, elio.peraza@nih.gov, through the pre-registration link, or during the webinar in the Q&A box.

Event registration, frequently asked questions (FAQs), recordings of the webinar (available after the event), and additional information may be found here:

Inquiries

Please direct all inquiries to:

Elio Peraza
National Institute of Neurological Disorders and Stroke (NINDS)
Email: elio.peraza@nih.gov?